675 related articles for article (PubMed ID: 26716645)
1. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
2. Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.
Huang D; Chowdhury S; Wang H; Savage SR; Ivey RG; Kennedy JJ; Whiteaker JR; Lin C; Hou X; Oberg AL; Larson MC; Eskandari N; Delisi DA; Gentile S; Huntoon CJ; Voytovich UJ; Shire ZJ; Yu Q; Gygi SP; Hoofnagle AN; Herbert ZT; Lorentzen TD; Calinawan A; Karnitz LM; Weroha SJ; Kaufmann SH; Zhang B; Wang P; Birrer MJ; Paulovich AG
Cell Rep Med; 2021 Dec; 2(12):100471. PubMed ID: 35028612
[TBL] [Abstract][Full Text] [Related]
3. Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression.
Sawyer BT; Qamar L; Yamamoto TM; McMellen A; Watson ZL; Richer JK; Behbakht K; Schlaepfer IR; Bitler BG
Mol Cancer Res; 2020 Jul; 18(7):1088-1098. PubMed ID: 32198139
[TBL] [Abstract][Full Text] [Related]
4. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
[TBL] [Abstract][Full Text] [Related]
5. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
Wang L; Li C; Song Y; Yan Z
Arch Biochem Biophys; 2020 Dec; 696():108664. PubMed ID: 33157102
[TBL] [Abstract][Full Text] [Related]
7. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
8. Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase.
Gao X; Li K; Hui X; Kong X; Sweeney G; Wang Y; Xu A; Teng M; Liu P; Wu D
Biochem J; 2011 May; 435(3):723-32. PubMed ID: 21348853
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid degradation plays an essential role in proliferation of mouse female primordial germ cells via the p53-dependent cell cycle regulation.
Teng H; Sui X; Zhou C; Shen C; Yang Y; Zhang P; Guo X; Huo R
Cell Cycle; 2016; 15(3):425-31. PubMed ID: 26716399
[TBL] [Abstract][Full Text] [Related]
10. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
11. ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells.
Yan H; Qiu L; Xie X; Yang H; Liu Y; Lin X; Huang H
Oncol Rep; 2017 Mar; 37(3):1412-1418. PubMed ID: 28184931
[TBL] [Abstract][Full Text] [Related]
12. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B
Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165
[TBL] [Abstract][Full Text] [Related]
13. Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
Pucci S; Zonetti MJ; Fisco T; Polidoro C; Bocchinfuso G; Palleschi A; Novelli G; Spagnoli LG; Mazzarelli P
Oncotarget; 2016 Apr; 7(15):19982-96. PubMed ID: 26799588
[TBL] [Abstract][Full Text] [Related]
14. CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma.
Tang M; Dong X; Xiao L; Tan Z; Luo X; Yang L; Li W; Shi F; Li Y; Zhao L; Liu N; Du Q; Xie L; Hu J; Weng X; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Cell Death Dis; 2022 Apr; 13(4):331. PubMed ID: 35411000
[TBL] [Abstract][Full Text] [Related]
15. CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.
Fang Y; Li Z; Wang X; Zhang S
Tumour Biol; 2012 Dec; 33(6):2299-306. PubMed ID: 22923389
[TBL] [Abstract][Full Text] [Related]
16. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth.
Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J
Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099
[TBL] [Abstract][Full Text] [Related]
17. SOX2 expression associates with stem cell state in human ovarian carcinoma.
Bareiss PM; Paczulla A; Wang H; Schairer R; Wiehr S; Kohlhofer U; Rothfuss OC; Fischer A; Perner S; Staebler A; Wallwiener D; Fend F; Fehm T; Pichler B; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Cancer Res; 2013 Sep; 73(17):5544-55. PubMed ID: 23867475
[TBL] [Abstract][Full Text] [Related]
18. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.
Wu GQ; Xie D; Yang GF; Liao YJ; Mai SJ; Deng HX; Sze J; Guan XY; Zeng YX; Lin MC; Kung HF
Int J Cancer; 2009 Dec; 125(11):2631-42. PubMed ID: 19672860
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]